Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment (Q48405388)

11 February 2018

title

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment (English)

1 reference

11 February 2018

1 reference

C Polidori

1

1 reference

11 February 2018

R Ciccocioppo

2

1 reference

11 February 2018

D Nisato

3

1 reference

11 February 2018

C Cazaubon

4

1 reference

11 February 2018

M Massi

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

11 February 2018

European Journal of Pharmacology

published in

1 reference

11 February 2018

volume

352

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

15-21

1 reference

11 February 2018

Intracerebroventricular angiotensin II-induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, Losartan (DuP 753), but not by the AT2 antagonist, CGP 42112B

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Ventricular obstruction: effect on drinking induced by intracranial injection of angiotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Effects of irbesartan (SR 47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Involvement of the renin-angiotensin system in captopril-induced sodium appetite in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Blockade of central angiotensin II type 1 and type 2 receptors suppresses adrenalectomy-induced NaCl intake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Regional expression of c-fos antigen in the basal forebrain following intraventricular infusions of angiotensin and its modulation by drinking either water or saline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Angiotensin II induces a complex activation of transcription factors in the rat brain: expression of Fos, Jun and Krox proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Functions of angiotensin in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Effect of nonpeptide angiotensin receptor antagonists on water intake and salt appetite in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contexts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Dependence of adrenalectomy-induced sodium appetite on the action of angiotensin II in the brain of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Access of peripherally administered DuP 753 to rat brain angiotensin II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Brain angiotensin receptor subtypes in the control of physiological and behavioral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900329-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00329-X

1 reference

11 February 2018

1 reference

11 February 2018